Vanda Pharmaceuticals, Inc.

NASDAQ: VNDA
$19.64
+$0.23 (+1.2%)
Closing price July 23, 2021
Given the fact that insider sales windows are closing fast as third-quarter earnings are imminent, it is pretty easy to understand the spike in selling volume we saw this past week.
Once again insiders were making transactions that may be getting done now in an effort to beat the closure of trading windows as third-quarter earnings season approaches.
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
One interesting tidbit to this week's insider trading was all the energy stocks that are showing up. It is clear many insiders feel the bottom is close and now is the time to buy shares.
Monday's top analyst upgrades and downgrades include Amazon.com, BlackBerry, F5 Networks, J.P. Morgan, Juniper Networks and United Continental.
The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have gleaned some interesting morsels that could be huge as the year wears on.
The stock market is up Tuesday, with the Dow Jones Industrial Average up 0.43%, the Nasdaq up 0.81%, and the S&P 500 up 0.62%. Today’s winners include a pharmaceutical company reporting a...
These are this Wednesday’s top ten analyst upgrades, downgrades, and initiations seen from today’s Wall Street research notes: Alliant Techsystems (NYSE: ATK) Raised to Outperform at...
These are this morning’s top day trader alert stocks.  We have more detailed price and volume analysis on each stock link over at VSInvestor.com: CIT Group Inc. (NYSE: CIT) is getting crushed...
These are some of the analyst downgrades and negative calls we are seeing early this Tuesday morning: Abercrombie & Fitch (ANF) Started as Neutral at Goldman Sachs. American Eagle Outfitters...
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China,...
Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a company update and clinical trial update at the Leerink Swann Cancer...